Autori: Tomasevic Zorica I
| Naslov | Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia (Article) |
| Autori | Krivokuca Ana M Boljevic Ivana Z Jovandic Stevo Magic Zvonko M Mandic Aljosa D Tomasevic Zorica I Brankovic-Magic Mirjana V |
| Info | JOURNAL OF HUMAN GENETICS, (2019), vol. 64 br. 4, str. 281-290 |
| Projekat | Ministry of Education, Science and Technological development of the Republic of Serbia [41026] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial (Article) |
| Autori | Chia Stephen KL ... Tomasevic Zorica I ... (broj koautora 26) |
| Info | BREAST CANCER RESEARCH, (2019), vol. 21 br. , str. - |
| Projekat | Wyeth; Pfizer; Puma Biotechnology; Puma Biotechnology Inc. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe (Article) |
| Autori | Vrdoljak Eduard ... Tomasevic Zorica I ... (broj koautora 16) |
| Info | ONCOLOGIST, (2019), vol. 24 br. 1, str. E30-E37 |
| Projekat | Roche |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial (Article) |
| Autori | von Minckwitz Gunter Colleoni Marco A Kolberg Hans-Christian Morales Serafin Santi Patricia Xavier Tomasevic Zorica I Zhang Nan Hanes Vladimir |
| Info | LANCET ONCOLOGY, (2018), vol. 19 br. 7, str. 987-998 |
| Projekat | Amgen |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Paclitaxel-induced peripheral neuropathy in patients with operable breast cancer (Meeting Abstract) |
| Autori | Serovic Kristina Tomasevic Zoran M Bozovic-Spasojevic Ivana M Minic Ivana Z Oblakovic-Babic Jelena S Jokic Vladimir Pusica Aleksandra Tomasevic Zorica I |
| Info | EUROPEAN JOURNAL OF CANCER, (2018), vol. 92 br. , Suppl. 3, str. S54-S54 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE (Article) |
| Autori | Popovic Lazar S Tomasevic Zorica I Stamatovic Ljiljana Markovic Ivan Z Matovina-Brko Gorana G Buta Marko N Golubovic Andrija Selakovic Vladimir Trifunovic Jasna D Mutrezani Zafir Ivanovic Nebojsa S Nedovic Jasmina R Ninkovic Srdjan M Filipovic Sladjana Cvetanovic Ana S Djordjevic Nebojsa P Karanikolic Aleksandar D Ivkovic-Kapicl Tatjana V Vicko Ferenc |
| Info | JOURNAL OF BUON, (2018), vol. 23 br. 2, str. 522-532 |
| Projekat | Serbian Society of Medical Oncology |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Safety results from a randomized, double-blind, phase 3 study of ABP 980 compared with trastuzumab in patients with breast cancer (Meeting Abstract) |
| Autori | Kolberg Hans-Christian Demetriou Georgia S Zhang Nan Tomasevic Zorica I Hanes Vladimir |
| Info | CANCER RESEARCH, (2018), vol. 78 br. 4, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial (Article) |
| Autori | Martin Miguel ... Tomasevic Zorica I ... (broj koautora 34) |
| Info | LANCET ONCOLOGY, (2017), vol. 18 br. 12, str. 1688-1700 |
| Projekat | Wyeth; Pfizer; Puma Biotechnology |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Family and personal cancer history in young patients with pregnancy associated breast cancer. (Meeting Abstract) |
| Autori | Tomasevic Zorica I Tomasevic Zoran M Bozovic-Spasojevic Ivana M Serovic Kristina Stojanovic Aleksandar Zdrale Zdravko Neric Dobrica Kovac Zeljko |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2016), vol. 34 br. 15, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Durable disease control in patients with metastatic breast cancer treated with single agent capecitabine. (Meeting Abstract) |
| Autori | Tomasevic Zoran M Tomasevic Zorica I Bozovic-Spasojevic Ivana M Serovic Kristina Stojanovic Aleksandar Zdrale Zdravko |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2016), vol. 34 br. 15, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
